Press Release: Octapharma : Octapharma's continuing dedication to improving the lives of people with rare bleeding disorders to be showcased at ISTH 2024
/PRNewswire/ -- The most recent developments from Octapharma's Haematology portfolio will be presented at the 32nd Congress of the International Society on...
Read full article »
Chairman & CEO
Wolfgang Marguerre
Octapharma is a Switzerland-based pharmaceutical company that develops, produces, and sells human proteins for immunotherapy and critical care patients
Read more